 LA JOLLA, Calif.--BUSINESS WIRE--- EQ--Equillium, Inc. Nasdaq: EQ, a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will participate in a fireside chat presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference, taking place September 27 30, 2021. Bruce Steel, Equilliums chief executive officer, and Dolca Thomas M.D., Equilliums executive vice president of re 